Recherches scientifiques au Luxembourg

La recherche en matière de drogues et d’addictions permet de mieux comprendre les problèmes liés à leur consommation et à l’évolution de l’usage, les nouvelles tendances, les nouveaux modes de consommation de drogue, les risques et dommages liés à la consommation,…

Voici un aperçu d’articles de recherche récents concernant la situation au Luxembourg :

  • Arendt, V., Guillorit, L., Origer, A., Sauvageot, N., Vaillant, M., Fischer, A., et al. (2019). Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. PLoSONE, 14(5):e0215570.https://doi.org/10.1371/journal.pone.0215570.

  • Berndt, N., Paulos, C. & Seixas, R. (2021). Mini-European Web Survey on Drugs: Impact of COVID-19 on drug use, acquisition behaviour and the drug market in Luxembourg. Luxembourg: Direction de la santé, Ministère de la Santé.https://sante.public.lu/fr/actualites/2021/04/enquete-drogues/report-mini-ewsd.pdf

  • Berndt, N., & Seixas, R. (2019). European Web Survey on Drugs: national implementation among a targeted sample of recreational drug users in Luxembourg 2018 [Enquête Européen sur les Drogues au G.D. de Luxembourg 2018]. Luxembourg: EMCDDA Luxembourg Focal Point - Point Focal Luxembourgeois de l’OEDT, Service épidémiologie et statistique, Direction de la santé. https://sante.public.lu/fr/publications/e/etat-drogue-europe-2019-factsheet-en/factsheet-eu-survey-drugs-2019.pdf

  • Berndt, N., Seixas, R. & Devaux, C. (2019). Combattre l'hépatite C chez les usagers de drogues injectables au Luxembourg : illustration d'une approche intersectorielle. Addictions : recherche et pratiques, 4, pp. 22-25.

  • Berndt, N., Seixas, R., Teyssier, E. & Origer, A. (2021). Etude de l‘impact de la COVID-19 sur les pratiques de consommation et l’utilisation des offres spécialisées par des usagers de drogues à haut-risque au Grand-Duché de Luxembourg. Luxembourg : Direction de la santé, Ministère de la Santé. https://www.emcdda.europa.eu/system/files/attachments/13931/Rapport-UDHR-COVID19-PFLDT-version-finale.pdf

  • Bourmaud, A., Dahm, G., Meys, F., Gengler, N., Origer, A. & Schneider, S. (2021). Investigation on heroin and cocaine quality in Luxembourg. Harm Reduction Journal 18, 97. https://doi.org/10.1186/s12954-021-00544-x

  • Fischer, A., Etienne, V., Guillorit, L., Biwersi, G., Origer, A., Devaux, C., Staub, T., & Arendt, V. (2017). Epidemiology of HIV and cascade of care in 2016 in injecting drug users from 1983 to 2016 in Luxembourg. IAS 2017 • 9th IAS Conference on HIV Science, 23 - 26 July 2017, Paris, France.http://www.ias2017.org/Portals/1/Files/IAS2017_LO.compressed.pdf?ver=2017-07-27-211231-197

  • Foulon, M. (2020). Etude sur la consommation de drogues en prison au Grand-Duché de Luxembourg (DU thèse pas publiée). Faculté de Médecine, Université Paris Sud, Paris.

  • Heinz, A., Kern, M. R., Residori, C., Catunda, C., van Duin, C., & Willems, H. (2018). Cannabiskonsum von Schülern in Luxemburg. HBSC-Factsheets Luxemburg Nr. 7 - http://orbilu.uni.lu/handle/10993/36404.

  • Hoffman, P., Arendt, V., Fischer, A., Menster, M., Etienne, V., Meyers, J., Conrath, M., Stein, R., Braunert, C., Foulon, M-L., & Seguin-Devaux, C. (2020). Combination disease prevention in prisons: a comprehensive programme in Luxembourg. In WHO (Eds.), Compendium of good practices in health sector response to viral hepatitis in the WHO European Region (pp. 50-53). Copenhagen: World Health Organization Regional Office for Europe.

  • Origer, A. (2017). A methodological inventory for the assessment of selected, unlabeled direct public expenditure in the field of drug demand reduction. In European Monitoring Centre for Drugs and Drug Addiction, Drug treatment expenditure: a methodological overview EMCDDA Insights 24. Luxembourg: Publications Office of the European Union. doi:10.2810/052028

  • Origer A., Le Bihan E., & Baumann, M. (2015). A Social Gradient in Fatal Opioids and
    Cocaine Related Overdoses? PLoS One., 10(5). doi: 10.1371/journal.pone.0125568.
    https://www.ncbi.nlm.nih.gov/pubmed/25938451

  • Origer A., Lopes da Costa S., & Baumann, M. (2014). Opiate and cocaine related fatal overdoses in Luxembourg from 1985 to 2011: A study on gender differences. Eur Addict Res., 20(2):87-93. doi:10.1159/000355170.
    http://www.ncbi.nlm.nih.gov/pubmed/24192492

  • Origer A., Le Bihan, E. & Baumann, M. (2014). Social and economic inequalities in fatal opiate and cocaine related overdoses in Luxembourg: A case-control study. Int. J. Drug Pol. doi: 10.1016/j.drugpo.2014.05.015.
    http://www.ncbi.nlm.nih.gov/pubmed/25002330

  • Origer A., & Schmit J.-C. (2012). Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence. J Epidemiol Community Health, 66, 64–68. doi:10.1136/jech.2009.101378.
    http://www.ncbi.nlm.nih.gov/pubmed/20889592

  • Origer, A. (2012). Prevalence of Problem Drug Use and Injecting Drug Use in Luxembourg: A Longitudinal and Methodological Perspective. Eur Addict Res., 18:288-296. doi:10.1159/000337211.
    http://www.ncbi.nlm.nih.gov/pubmed/22854631

  • Buchicchio, L., Asselborn, L., Schneider, S. et al. (2022). Investigation of aflatoxin and ochratoxin A contamination of seized cannabis and cannabis resin samples. Mycotoxin Res, 38, 71–78.https://doi.org/10.1007/s12550-022-00449-z

  • Removille, N., Origer, A., Couffignal, S., Vaillant, M., Schmit, J-C, & Lair, ML (2011). A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. BMC Public Health, 11(1):351.
    http://www.ncbi.nlm.nih.gov/pubmed/21595969

  • Schneider, S. & Meys, F. (2011). Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005– 2010, Forensic Sci. Int. doi:10.1016/j.forsciint.2011.06.027.
    http://www.ncbi.nlm.nih.gov/pubmed/21767923

Publications

Dernière modification le